Oncolin Therapeutics, Inc.
SEC CIK 1229089 · ocol · last insider filing 2015-11-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baez Cesar A | Director | filed 2015 - 2015 |
| Faulkner Chris Aundre | Director · CEO, President & Chairman | filed 2013 - 2015 |
| Thornock Trenton T. | Director | filed 2014 - 2014 |
| Williford Chris E | Director | filed 2013 - 2014 |
| Plumb Steven M | Director · President & CFO | filed 2013 - 2014 |
| Ivins James Leonard | Director · Chief Executive Officer | filed 2013 - 2014 |
| Huberman Jonathan | Director | filed 2013 - 2013 |
| Hoover Judson F | Director | filed 2013 - 2013 |
| Mourglia Richard H | Director | filed 2013 - 2013 |
| Casey Kevan | Director · Corporate Secretary | filed 2009 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kovacs David J | Executive Vice President | filed 2014 - 2014 |
| Wagers Jeremy Scott | COO and General Counsel | filed 2013 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.